Charles M Ewing

Charles M Ewing

UNVERIFIED PROFILE

Are you Charles M Ewing?   Register this Author

Register author
Charles M Ewing

Charles M Ewing

Publications by authors named "Charles M Ewing"

Are you Charles M Ewing?   Register this Author

31Publications

633Reads

11Profile Views

HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.

Prostate 2019 Mar 17;79(4):414-424. Epub 2018 Dec 17.

Brady Urological Institute, Johns Hopkins University, School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23747DOI Listing
March 2019

Germline mutations in PPFIBP2 are associated with lethal prostate cancer.

Prostate 2018 12 24;78(16):1222-1228. Epub 2018 Jul 24.

Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23697DOI Listing
December 2018

Genetic factors influencing prostate cancer risk in Norwegian men.

Prostate 2018 02 27;78(3):186-192. Epub 2017 Nov 27.

Brady Urological Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23453DOI Listing
February 2018

The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.

Cancer Epidemiol Biomarkers Prev 2015 Sep 24;24(9):1366-72. Epub 2015 Jun 24.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560608PMC
September 2015

Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts.

J Cell Mol Med 2012 Jan;16(1):193-201

Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2011.01283.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823105PMC
January 2012

Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.

Int J Cancer 2011 Jul 16;129(2):424-32. Epub 2010 Nov 16.

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25705DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040782PMC
July 2011

Endoglin (CD105) as a urinary and serum marker of prostate cancer.

Int J Cancer 2009 Feb;124(3):664-9

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666305PMC
February 2009

alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling.

Mol Cancer Ther 2008 Jun;7(6):1386-97

Nemours Center for Childhood Cancer Research, Alfred I. DuPont Hospital for Children, 1701 Rockland Road, Wilmington, DE 19803, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-2029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527861PMC
June 2008

Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers.

Genes Chromosomes Cancer 2007 Nov;46(11):972-80

Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20482DOI Listing
November 2007

Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.

Hum Genet 2006 Nov 25;120(4):471-85. Epub 2006 Aug 25.

Harwick 7, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00439-006-0219-9DOI Listing
November 2006

A novel role of myosin VI in human prostate cancer.

Am J Pathol 2006 Nov;169(5):1843-54

Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1780223PMC
http://dx.doi.org/10.2353/ajpath.2006.060316DOI Listing
November 2006

Germline ATBF1 mutations and prostate cancer risk.

Prostate 2006 Jul;66(10):1082-5

Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20430DOI Listing
July 2006

Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.

Exp Cell Res 2006 Apr 17;312(6):831-43. Epub 2006 Jan 17.

Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2005.11.029DOI Listing
April 2006

A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.

Am J Hum Genet 2005 Aug 29;77(2):219-29. Epub 2005 Jun 29.

Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/432377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224525PMC
August 2005

Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells.

Cancer Res 2004 Apr;64(7):2523-33

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
April 2004

Cadherin-6: a new prognostic marker for renal cell carcinoma.

J Urol 2004 Jan;171(1):97-101

Department of Urology, Technischen Universitaet Munich, Klinikum rechts der Isar, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000101512.47242.79DOI Listing
January 2004

Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.

Cancer Res 2003 Nov;63(21):7365-76

Brady Urological Institute, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
November 2003

Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.

Prostate 2003 Oct;57(2):134-9

Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.10284DOI Listing
October 2003

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Cancer Res 2002 Apr;62(8):2220-6

Department of Pathology, Brady Urological Institute, Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
April 2002

In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.

Oncogene 2002 Apr;21(17):2679-94

Brady Urological Institute Research Laboratories, The Johns Hopkins Medical Institutions, Baltimore, Maryland, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205352DOI Listing
April 2002